9-76707152-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000376718.8(PRUNE2):​c.5122C>A​(p.His1708Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.588 in 1,613,426 control chromosomes in the GnomAD database, including 281,638 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.54 ( 23291 hom., cov: 31)
Exomes 𝑓: 0.59 ( 258347 hom. )

Consequence

PRUNE2
ENST00000376718.8 missense

Scores

17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.01

Publications

27 publications found
Variant links:
Genes affected
PRUNE2 (HGNC:25209): (prune homolog 2 with BCH domain) The protein encoded by this gene belongs to the B-cell CLL/lymphoma 2 and adenovirus E1B 19 kDa interacting family, whose members play roles in many cellular processes including apotosis, cell transformation, and synaptic function. Several functions for this protein have been demonstrated including suppression of Ras homolog family member A activity, which results in reduced stress fiber formation and suppression of oncogenic cellular transformation. A high molecular weight isoform of this protein has also been shown to colocalize with Adaptor protein complex 2, beta-Adaptin and endodermal markers, suggesting an involvement in post-endocytic trafficking. In prostate cancer cells, this gene acts as a tumor suppressor and its expression is regulated by prostate cancer antigen 3, a non-protein coding gene on the opposite DNA strand in an intron of this gene. Prostate cancer antigen 3 regulates levels of this gene through formation of a double-stranded RNA that undergoes adenosine deaminase actin on RNA-dependent adenosine-to-inosine RNA editing. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
PCA3 (HGNC:8637): (prostate cancer associated 3) This gene produces a spliced, long non-coding RNA that is highly overexpressed in most types of prostate cancer cells and is used as a specific biomarker for this type of cancer. This gene is embedded in an intronic region of the prune2 gene on the opposite DNA strand. The transcript regulates prune2 levels through formation of a double-stranded RNA that undergoes adenosine deaminase acting on RNA-dependent adenosine-to-inosine RNA editing. In prostate cancer derived cells, overexpression of PCA induced downregulation of prune2, leading to decreased cell proliferation. Conversely, silencing in prostate cancer cells resulted in increased proliferation. Regulation of this gene appears to be sensitive to androgen-receptor activation, a molecular signature of prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.676775E-6).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.639 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000376718.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRUNE2
NM_015225.3
MANE Select
c.5122C>Ap.His1708Asn
missense
Exon 8 of 19NP_056040.2
PRUNE2
NM_001308048.2
c.5122C>Ap.His1708Asn
missense
Exon 8 of 18NP_001294977.1
PRUNE2
NM_001308047.2
c.5122C>Ap.His1708Asn
missense
Exon 8 of 18NP_001294976.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRUNE2
ENST00000376718.8
TSL:5 MANE Select
c.5122C>Ap.His1708Asn
missense
Exon 8 of 19ENSP00000365908.3
PRUNE2
ENST00000443509.6
TSL:5
c.5122C>Ap.His1708Asn
missense
Exon 8 of 18ENSP00000393843.3
PRUNE2
ENST00000428286.5
TSL:5
c.4045C>Ap.His1349Asn
missense
Exon 8 of 19ENSP00000397425.1

Frequencies

GnomAD3 genomes
AF:
0.544
AC:
82585
AN:
151792
Hom.:
23276
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.403
Gnomad AMI
AF:
0.401
Gnomad AMR
AF:
0.651
Gnomad ASJ
AF:
0.722
Gnomad EAS
AF:
0.453
Gnomad SAS
AF:
0.571
Gnomad FIN
AF:
0.520
Gnomad MID
AF:
0.725
Gnomad NFE
AF:
0.605
Gnomad OTH
AF:
0.611
GnomAD2 exomes
AF:
0.590
AC:
146485
AN:
248234
AF XY:
0.594
show subpopulations
Gnomad AFR exome
AF:
0.392
Gnomad AMR exome
AF:
0.702
Gnomad ASJ exome
AF:
0.711
Gnomad EAS exome
AF:
0.452
Gnomad FIN exome
AF:
0.515
Gnomad NFE exome
AF:
0.610
Gnomad OTH exome
AF:
0.615
GnomAD4 exome
AF:
0.592
AC:
865367
AN:
1461516
Hom.:
258347
Cov.:
52
AF XY:
0.593
AC XY:
431281
AN XY:
727038
show subpopulations
African (AFR)
AF:
0.393
AC:
13170
AN:
33478
American (AMR)
AF:
0.692
AC:
30948
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.709
AC:
18522
AN:
26134
East Asian (EAS)
AF:
0.462
AC:
18334
AN:
39698
South Asian (SAS)
AF:
0.584
AC:
50348
AN:
86252
European-Finnish (FIN)
AF:
0.517
AC:
27587
AN:
53374
Middle Eastern (MID)
AF:
0.722
AC:
4165
AN:
5768
European-Non Finnish (NFE)
AF:
0.599
AC:
666449
AN:
1111734
Other (OTH)
AF:
0.594
AC:
35844
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
20301
40602
60904
81205
101506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18082
36164
54246
72328
90410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.544
AC:
82643
AN:
151910
Hom.:
23291
Cov.:
31
AF XY:
0.543
AC XY:
40346
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.403
AC:
16695
AN:
41418
American (AMR)
AF:
0.650
AC:
9919
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
2503
AN:
3468
East Asian (EAS)
AF:
0.453
AC:
2334
AN:
5154
South Asian (SAS)
AF:
0.573
AC:
2752
AN:
4804
European-Finnish (FIN)
AF:
0.520
AC:
5492
AN:
10560
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.605
AC:
41086
AN:
67936
Other (OTH)
AF:
0.609
AC:
1287
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1834
3668
5503
7337
9171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
79796
Bravo
AF:
0.546
TwinsUK
AF:
0.595
AC:
2208
ALSPAC
AF:
0.602
AC:
2319
ESP6500AA
AF:
0.408
AC:
1278
ESP6500EA
AF:
0.616
AC:
4415
ExAC
AF:
0.583
AC:
70164
Asia WGS
AF:
0.492
AC:
1708
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
2.7
DANN
Benign
0.46
DEOGEN2
Benign
0.0028
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.0000057
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.0
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.040
N
REVEL
Benign
0.061
Sift
Benign
0.39
T
Sift4G
Benign
0.32
T
Polyphen
0.0050
B
Vest4
0.11
MPC
0.099
ClinPred
0.0081
T
GERP RS
5.2
Varity_R
0.082
gMVP
0.040
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs683866; hg19: chr9-79322068; COSMIC: COSV65039678; COSMIC: COSV65039678; API